Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G F Watts

Showing results (121-130 of 198) with videos related to

Pageof 20
Sort By:
Circulation|September 12, 2000
Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight menT A Mori, G F Watts, V Burke, et al.
Journal of Lipid Research|March 8, 2000
Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesityG F Watts, F M Riches, S E Humphries, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 14, 2001
Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?J C Mamo, G F Watts, P H Barrett, et al.
Metabolism: Clinical and Experimental|November 1, 1993
Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS)G F Watts, S Mandalia, J N Brunt, et al.
Atherosclerosis|November 1, 1993
Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipaseP J Pacy, K A Mitropoulos, S Venkatesan, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|June 25, 2003
Effect of a statin on hepatic apolipoprotein B-100 secretion and plasma campesterol levels in the metabolic syndromeG F Watts, D C Chan, P H R Barrett, et al.
Journal of Clinical Pathology|August 1, 1994
Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patientsJ C Mazurkiewicz, G F Watts, F G Warburton, et al.
QJM : Monthly Journal of the Association of Physicians|May 1, 1995
Lipoprotein(a) as a determinant of the severity of angiographically defined carotid atherosclerosisG F Watts, J C Mazurkiewicz, K Tonge, et al.
Clinical Chemistry|December 1, 1994
Metabolic determinants of the course of coronary artery disease in menG F Watts, S Mandalia, B M Slavin, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 1999
Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese menF M Riches, G F Watts, J Hua, et al.
Pageof 20

Showing results (121-130 of 198) with videos related to

Sort By:
Pageof 20
Circulation|September 12, 2000
Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight menT A Mori, G F Watts, V Burke, et al.
Journal of Lipid Research|March 8, 2000
Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesityG F Watts, F M Riches, S E Humphries, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 14, 2001
Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?J C Mamo, G F Watts, P H Barrett, et al.
Metabolism: Clinical and Experimental|November 1, 1993
Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS)G F Watts, S Mandalia, J N Brunt, et al.
Atherosclerosis|November 1, 1993
Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipaseP J Pacy, K A Mitropoulos, S Venkatesan, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|June 25, 2003
Effect of a statin on hepatic apolipoprotein B-100 secretion and plasma campesterol levels in the metabolic syndromeG F Watts, D C Chan, P H R Barrett, et al.
Journal of Clinical Pathology|August 1, 1994
Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patientsJ C Mazurkiewicz, G F Watts, F G Warburton, et al.
QJM : Monthly Journal of the Association of Physicians|May 1, 1995
Lipoprotein(a) as a determinant of the severity of angiographically defined carotid atherosclerosisG F Watts, J C Mazurkiewicz, K Tonge, et al.
Clinical Chemistry|December 1, 1994
Metabolic determinants of the course of coronary artery disease in menG F Watts, S Mandalia, B M Slavin, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 1999
Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese menF M Riches, G F Watts, J Hua, et al.
Pageof 20